Patents by Inventor Jared T. Wilsey

Jared T. Wilsey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11369752
    Abstract: An approach is provided for delivering therapeutic materials to an intervertebral disc via a sub-ligamentous space. The approach includes positioning a tool at an interface of a longitudinal ligament and an outer surface of the intervertebral disc, in which the interface is the sub-ligamentous space. The tool may include a first needle and a second needle housed within the first needle. An insertion end of the first needle may include a shallow beveled end. The approach includes inserting the insertion end of the first needle into the sub-ligamentous space. The approach includes deploying the second needle from within the first needle into at least one of an annulus and a nucleus of the intervertebral disc. The approach includes delivering the therapeutic materials to the at least one of the annulus and the nucleus.
    Type: Grant
    Filed: April 22, 2019
    Date of Patent: June 28, 2022
    Assignee: WARSAW ORTHOPEDIC, INC.
    Inventors: Jared T. Wilsey, Keith E. Miller, Benjamin T. Reves
  • Patent number: 11357756
    Abstract: Effective implantable medical devices and methods for reducing and treating acute pain by providing local anesthesia and nerve blockade using an imidazoline compound, such as clonidine are provided. In some embodiments, there is an injectable pharmaceutical composition comprising a therapeutically effective amount of imidazoline compound in a liquid pharmaceutical carrier, where the imidazoline compound provides local anesthesia and nerve block to the target tissue site which is a dorsal root ganglion, peripheral nerve fiber and/or peripheral nerve root.
    Type: Grant
    Filed: January 19, 2018
    Date of Patent: June 14, 2022
    Assignee: Warsaw Orthopedic, Inc.
    Inventor: Jared T. Wilsey
  • Publication number: 20210121428
    Abstract: This invention is directed to novel compositions containing a source of precursors to Type I collagen, an collagenic organic acid, an aldehyde, a polyol, an aldose, esters or salts or any combinations thereof, a blend of collagenic monomers or short-chain polymers, and a thickening agent to optimize the viscosity of the delivery system and methods of using such compositions for promoting collagen synthesis in the annular region of intervertebral disc.
    Type: Application
    Filed: October 25, 2019
    Publication date: April 29, 2021
    Inventors: Jared T. Wilsey, David S. Scher
  • Publication number: 20200338307
    Abstract: A method of delivering a therapeutic agent to a nucleus pulposus of an intervertebral disc is provided. The method comprises inserting a delivery tool containing the therapeutic agent through an anterior portion, a lateral portion, or an anterolateral portion of an annulus fibrosus and into the nucleus pulposus of the intervertebral disc; and delivering the therapeutic agent to the nucleus pulposus of the intervertebral disc. Devices and kits are also provided.
    Type: Application
    Filed: April 25, 2019
    Publication date: October 29, 2020
    Inventors: Benjamin T. Reves, Todd M. Boyce, Daniel A. Shimko, Jared T. Wilsey
  • Publication number: 20200330702
    Abstract: An approach is provided for delivering therapeutic materials to an intervertebral disc via a sub-ligamentous space. The approach includes positioning a tool at an interface of a longitudinal ligament and an outer surface of the intervertebral disc, in which the interface is the sub-ligamentous space. The tool may include a first needle and a second needle housed within the first needle. An insertion end of the first needle may include a shallow beveled end. The approach includes inserting the insertion end of the first needle into the sub-ligamentous space. The approach includes deploying the second needle from within the first needle into at least one of an annulus and a nucleus of the intervertebral disc. The approach includes delivering the therapeutic materials to the at least one of the annulus and the nucleus.
    Type: Application
    Filed: April 22, 2019
    Publication date: October 22, 2020
    Inventors: JARED T. WILSEY, Keith E. Miller, Benjamin T. Reves
  • Publication number: 20180207133
    Abstract: Effective implantable medical devices and methods for reducing and treating acute pain by providing local anesthesia and nerve blockade using an imidazoline compound, such as clonidine are provided. In some embodiments, there is an injectable pharmaceutical composition comprising a therapeutically effective amount of imidazoline compound in a liquid pharmaceutical carrier, where the imidazoline compound provides local anesthesia and nerve block to the target tissue site which is a dorsal root ganglion, peripheral nerve fiber and/or peripheral nerve root.
    Type: Application
    Filed: January 19, 2018
    Publication date: July 26, 2018
    Inventor: Jared T. Wilsey
  • Patent number: 9968572
    Abstract: Effective treatments of pain for extended periods of time are provided. Through the administration of an effective amount of clonidine and a gamma-aminobutyric acid compound at or near a target site, one can relieve pain caused by diverse sources, including but not limited to spinal disc herniation (i.e. sciatica), spondilothesis, stenosis, discogenic back pain and joint pain, as well as pain that is incidental to surgery. When appropriate formulations are provided within biodegradable polymers, this relief can be continued for at least three days. In some embodiments, the relief can be for at least twenty-five days, at least fifty days, at least one hundred days, at least one hundred and thirty-five days or at least one hundred and eighty days.
    Type: Grant
    Filed: March 31, 2016
    Date of Patent: May 15, 2018
    Assignee: Warsaw Orthopedic, Inc.
    Inventors: Jared T. Wilsey, Danielle L. Clay, Jeffrey C. Marx, William F. McKay, Josee Roy, John Myers Zanella
  • Patent number: 9592243
    Abstract: Improved medical devices and methods are provided comprising an anabolic agent for healing an injury. These improved medical devices and methods can enhance healing in injuries from traumatic soft tissue injury, surgical injuries, burn, traumatic brain injuries, musculotendinous injuries, musculoskeletal conditions, bone injury or other injuries or maladies, which can be chronic or non-chronic in origin. In some embodiments, the medical device comprises a drug depot that releases the anabolic agent over at least 2 days to enhance healing of an injury.
    Type: Grant
    Filed: November 20, 2013
    Date of Patent: March 14, 2017
    Assignee: Warsaw Orthopedic, Inc.
    Inventor: Jared T. Wilsey
  • Patent number: 9511077
    Abstract: Improved medical devices and methods are provided comprising an anabolic agent for wound healing. These improved medical devices and methods can enhance wound healing in wounds from cuts, abrasions, lesions, burns including sunburn, surgical incisions, pressure ulcers, diabetic ulcers, traumatic wounds, or other injuries or maladies, which can be chronic or non-chronic in origin. In some embodiments, the medical device comprises a drug depot that releases the anabolic agent over at least 3 days to enhance wound healing.
    Type: Grant
    Filed: April 25, 2011
    Date of Patent: December 6, 2016
    Assignee: Warsaw Orthopedic, Inc.
    Inventors: Danielle L. Biggs, Jared T. Wilsey
  • Publication number: 20160213630
    Abstract: Effective treatments of pain for extended periods of time are provided. Through the administration of an effective amount of clonidine and a gamma-aminobutyric acid compound at or near a target site, one can relieve pain caused by diverse sources, including but not limited to spinal disc herniation (i.e. sciatica), spondilothesis, stenosis, discogenic back pain and joint pain, as well as pain that is incidental to surgery. When appropriate formulations are provided within biodegradable polymers, this relief can be continued for at least three days. In some embodiments, the relief can be for at least twenty-five days, at least fifty days, at least one hundred days, at least one hundred and thirty-five days or at least one hundred and eighty days.
    Type: Application
    Filed: March 31, 2016
    Publication date: July 28, 2016
    Inventors: Jared T. Wilsey, Danielle L. Clay, Jeffrey C. Marx, William F. McKay, Josee Roy, John Myers Zanella
  • Patent number: 9301946
    Abstract: Effective treatments of pain for extended periods of time are provided. Through the administration of an effective amount of clonidine and a gamma-aminobutyric acid compound at or near a target site, one can relieve pain caused by diverse sources, including but not limited to spinal disc herniation (i.e. sciatica), spondilothesis, stenosis, discogenic back pain and joint pain, as well as pain that is incidental to surgery. When appropriate formulations are provided within biodegradable polymers, this relief can be continued for at least three days. In some embodiments, the relief can be for at least twenty-five days, at least fifty days, at least one hundred days, at least one hundred and thirty-five days or at least one hundred and eighty days.
    Type: Grant
    Filed: December 2, 2011
    Date of Patent: April 5, 2016
    Assignee: Warsaw Orthopedic, Inc.
    Inventors: Jared T. Wilsey, Danielle L. Biggs, Jeffrey C. Marx, William F. McKay, Josee Roy, John Myers Zanella
  • Publication number: 20150342964
    Abstract: A biodegradable drug implant for reducing, preventing or treating pain and/or inflammation in a patient is provided. The biodegradable drug implant comprises dexamethasone and a polylactic acid polyglycolic acid (PLGA) copolymer matrix, wherein the dexamethasone comprises from about 50% to about 80% by weight of the drug implant. Methods of treating pain in a patient are also provided.
    Type: Application
    Filed: May 30, 2014
    Publication date: December 3, 2015
    Applicant: Warsaw Orthopedic, Inc.
    Inventors: Jonathan Gray, Jeffrey C. Marx, William F. McKay, Josee Roy, Jared T. Wilsey
  • Publication number: 20140107088
    Abstract: Improved medical devices and methods are provided comprising an anabolic agent for healing an injury. These improved medical devices and methods can enhance healing in injuries from traumatic soft tissue injury, surgical injuries, burn, traumatic brain injuries, musculotendinous injuries, musculoskeletal conditions, bone injury or other injuries or maladies, which can be chronic or non-chronic in origin. In some embodiments, the medical device comprises a drug depot that releases the anabolic agent over at least 2 days to enhance healing of an injury.
    Type: Application
    Filed: November 20, 2013
    Publication date: April 17, 2014
    Applicant: Warsaw Orthopedic, Inc.
    Inventor: Jared T. Wilsey
  • Patent number: 8623396
    Abstract: Effective treatments of pain for extended periods of time are provided. Through the administration of an effective amount of immediate release bupivacaine or lidocaine and a sustained release clonidine at or near a target site, one can relieve pain caused by diverse sources, including but not limited to spinal disc herniation (i.e. sciatica), spondilothesis, stenosis, discogenic back pain and joint pain. When appropriate formulations are provided within biodegradable polymers, this relief can be continued for at least three days. In some embodiments, the relief can be for at least twenty-five days, at least fifty days, at least one hundred days, at least one hundred and thirty-five days or at least one hundred and eighty days or longer.
    Type: Grant
    Filed: December 2, 2011
    Date of Patent: January 7, 2014
    Assignee: Warsaw Orthopedic, Inc.
    Inventors: Jonathan K. Gray, Jeffrey C. Marx, William F. McKay, Josee Roy, Danielle L. Clay, Jared T. Wilsey, John Myers Zanella
  • Publication number: 20130217673
    Abstract: Effective treatments of pain for extended periods of time are provided. Through the administration of an effective amount of mixed monoamine reuptake inhibitor locally at or near a target site, one can relieve pain caused by diverse sources, including but not limited to spinal disc herniation (i.e. sciatica), spondilothesis, stenosis, discogenic back pain and joint pain, as well as pain that is incidental to surgery. When appropriate formulations are provided within biodegradable polymers, this relief can be continued for at least thirty days. In some embodiments, the relief can be for at least at least fifty days, at least one hundred days, at least one hundred and twenty days, at least one hundred and thirty, at least one hundred fifty days or at least one hundred and eighty days.
    Type: Application
    Filed: February 22, 2012
    Publication date: August 22, 2013
    Applicant: Warsaw Orthopedic, Inc
    Inventor: Jared T. Wilsey
  • Publication number: 20120271275
    Abstract: Improved medical devices and methods are provided comprising an anabolic agent for wound healing. These improved medical devices and methods can enhance wound healing in wounds from cuts, abrasions, lesions, burns including sunburn, surgical incisions, pressure ulcers, diabetic ulcers, traumatic wounds, or other injuries or maladies, which can be chronic or non-chronic in origin. In some embodiments, the medical device comprises a drug depot that releases the anabolic agent over at least 3 days to enhance wound healing.
    Type: Application
    Filed: April 25, 2011
    Publication date: October 25, 2012
    Applicant: WARSAW ORTHOPEDIC, INC.
    Inventors: Danielle L. Biggs, Jared T. Wilsey
  • Publication number: 20120142648
    Abstract: Effective treatments of pain for extended periods of time are provided. Through the administration of an effective amount of clonidine and a steroid at or near a target site, one can relieve pain caused by diverse sources, including but not limited to spinal disc herniation (i.e. sciatica), spondilothesis, stenosis, discogenic back pain and joint pain. When appropriate formulations are provided within biodegradable polymers, this relief can be continued for at least three days. In some embodiments, the relief can be for at least twenty-five days, at least fifty days, at least one hundred days, at least one hundred and thirty-five days or at least one hundred and eighty days.
    Type: Application
    Filed: December 2, 2011
    Publication date: June 7, 2012
    Applicant: Warsaw Orthopedic, Inc.
    Inventors: Danielle L. Biggs, Jonathan K. Gray, Jeffrey C. Marx, William F. McKay, Josee Roy, Jared T. Wilsey, John Myers Zanella
  • Publication number: 20120142649
    Abstract: Effective treatments of pain for extended periods of time are provided. Through the administration of an effective amount of immediate release bupivacaine or lidocaine and a sustained release clonidine at or near a target site, one can relieve pain caused by diverse sources, including but not limited to spinal disc herniation (i.e. sciatica), spondilothesis, stenosis, discogenic back pain and joint pain. When appropriate formulations are provided within biodegradable polymers, this relief can be continued for at least three days. In some embodiments, the relief can be for at least twenty-five days, at least fifty days, at least one hundred days, at least one hundred and thirty-five days or at least one hundred and eighty days or longer.
    Type: Application
    Filed: December 2, 2011
    Publication date: June 7, 2012
    Applicant: Warsaw Orthopedic, Inc.
    Inventors: Jonathan K. Gray, Jeffrey C. Marx, William F. McKay, Josee Roy, Danielle L. Clay, Jared T. Wilsey, John Myers Zanella
  • Publication number: 20120142643
    Abstract: Effective treatments of pain for extended periods of time are provided. Through the administration of an effective amount of clonidine and a gamma-aminobutyric acid compound at or near a target site, one can relieve pain caused by diverse sources, including but not limited to spinal disc herniation (i.e. sciatica), spondilothesis, stenosis, discogenic back pain and joint pain, as well as pain that is incidental to surgery. When appropriate formulations are provided within biodegradable polymers, this relief can be continued for at least three days. In some embodiments, the relief can be for at least twenty-five days, at least fifty days, at least one hundred days, at least one hundred and thirty-five days or at least one hundred and eighty days.
    Type: Application
    Filed: December 2, 2011
    Publication date: June 7, 2012
    Applicant: Warsaw Orthopedic, Inc.
    Inventors: Jared T. Wilsey, Danielle L. Biggs, Jeffrey C. Marx, William F. McKay, Josee Roy, John Myers Zanella
  • Publication number: 20120142747
    Abstract: Effective treatments of pain for extended periods of time are provided. Through the administration of an effective amount of immediate release clonidine and a sustained release clonidine at or near a target site, one can relieve pain caused by diverse sources, including but not limited to spinal disc herniation (i.e. sciatica), spondilothesis, stenosis, discogenic back pain and joint pain. When appropriate formulations are provided within biodegradable polymers, this relief can be continued for at least three days. In some embodiments, the relief can be for at least twenty-five days, at least fifty days, at least one hundred days, at least one hundred and thirty-five days or at least one hundred and eighty days or longer.
    Type: Application
    Filed: December 2, 2011
    Publication date: June 7, 2012
    Applicant: Warsaw Orthopedic, Inc.
    Inventors: Jared T. Wilsey, Danielle L. Biggs, Jonathan K. Gray, Jeffrey C. Marx, William F. McKay, Josee Roy, John Myers Zanella